Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut is a clinical research site located in Plainville, Connecticut, United States 06062.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Advanced Solid Tumors, Relapsed or Refractory Multiple Myeloma, Small Cell Lung Cancer (SCLC).
Sponsors: Astellas Pharma Global Development, Inc., Amgen.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut has 3 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumors, Relapsed or Refractory Multiple Myeloma, Small Cell Lung Cancer (SCLC).
Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.